Numerous epidemiological studies have suggested effectiveness of long-term and regular use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and aspirin, in preventing and treatment of certain cancers including prostate, colon, breast, lung, and gastric cancers. We have studied the potential anti-turmeric effect of ibuprofen in adenocarcinoma gastric cell line (AGS). The effects of ibuprofen were investigated on cell proliferation, apoptosis, angiogenesis, and expression of stemness marker genes using real-time RT-PCR, DNA laddering, and tube formation assays via ECM gel and human umbilical vein endothelial cells (HUVECs). Annexin-V-FLUOS and propidium iodide (PI) were used to stain the apoptotic cells. Our findings indicate that ibuprofen at the concentrations of 100, 200, 300, 400, and 500 μM is able to reduce the cancerous characteristics of the AGS cells by inducing apoptosis, inhibition of cell proliferation, and angiogenesis. Real-time RT-PCR showed that ibuprofen altered the expression of several genes including Akt, P53, PCNA, Bax, and Bcl2 in the AGS cells. In addition, reduction in CD44 and OCT3/4 transcript levels revealed that ibuprofen reduces the stemness of the AGS cells and therefore it could be used as a potential anti-tumor drug.
Angiogenesis Apoptosis Adenocarcinoma gastric cell line (AGS) Gastric cancer Ibuprofen
This is a preview of subscription content, log in to check access.
The authors are grateful to Fatemeh Mahmoodi and Kamran Mansouri for their contribution in completing this work. We would like to thank Dr. Sajjad Sisakhtnezhad for reviewing the manuscript.
Conflicts of interest
Takahashi T, Saikawa Y, Kitagawa Y. Gastric cancer: current status of diagnosis and treatment. Cancer. 2013;5(1):48–63.CrossRefGoogle Scholar
Raegg C, Dormond O. Suppression of tumor angiogenesis by nonsteroidal anti-inflammatory drugs: a new function for old drugs. Sci World J. 2001;1:808–11.CrossRefGoogle Scholar
Yao M, Zhou W, Sangha S, Albert A, Chang AJ, Liu TC, et al. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer. Clin Cancer Res. 2005;11(4):1618–28.CrossRefPubMedGoogle Scholar
Bonelli P, Tuccillo F, Calemma R, Pezzetti F, Borrelli A, Martinelli R, et al. Changes in the gene expression profile of gastric cancer cells in response to ibuprofen: a gene pathway analysis. Pharmacogenomics J. 2010;11(6):412–28.CrossRefPubMedGoogle Scholar
Andrews J, Djakiew D, Krygier S, Andrews P. Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells. Cancer Chemother Pharmacol. 2002;50(4):277–84.CrossRefPubMedGoogle Scholar
Redpath M, Marques C, Dibden C, Waddon A, Lalla R, MacNeil S. Ibuprofen and hydrogel‐released ibuprofen in the reduction of inflammation‐induced migration in melanoma cells. Br J Dermatol. 2009;161(1):25–33.CrossRefPubMedGoogle Scholar
Janssen A, Schiffmann S, Birod K, Maier TJ, Wobst I, Geisslinger G, et al. p53 is important for the anti-proliferative effect of ibuprofen in colon carcinoma cells. Biochem Biophys Res Commun. 2008;365(4):698–703.CrossRefPubMedGoogle Scholar
Lincová E, Hampl A, Pernicová Z, Staršíchová A, Krčmář P, Machala M, et al. Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs. Biochem Pharmacol. 2009;78(6):561–72.CrossRefPubMedGoogle Scholar
Jun DY, Rue SW, Han KH, Taub D, Lee YS, Bae YS, et al. Mechanism underlying cytotoxicity of thialysine, lysine analog, toward human acute leukemia Jurkat T cells. Biochem Pharmacol. 2003;66(12):2291–300.CrossRefPubMedGoogle Scholar
Węglarz1½ L, Molin I, Orchel A, Parfiniewicz B, Dzierżewicz Z. Quantitative analysis of the level of p53 and p21WAF1 mRNA in human colon cancer HT-29 cells treated with inositol hexaphosphate. 2006.Google Scholar
Khwaja F, Allen J, Lynch J, Andrews P, Djakiew D. Ibuprofen inhibits survival of bladder cancer cells by induced expression of the p75NTR tumor suppressor protein. Cancer Res. 2004;64(17):6207–13.CrossRefPubMedGoogle Scholar
Zhou XM, Wong BCY, Fan XM, Zhang HB, Lin MCM, Kung HF, et al. Non-steroidal anti-inflammatory drugs apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis. 2001;22:1393–7.CrossRefPubMedGoogle Scholar
Liou J-Y, Ghelani D, Yeh S, Wu KK. Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3ε. Cancer Res. 2007;67(7):3185–91.CrossRefPubMedGoogle Scholar
Bonelli P, Tuccillo FM, Federico A, Napolitano M, Borrelli A, Melisi D, et al. Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations. Int J Nanomedicine. 2012;7:5683.CrossRefPubMedPubMedCentralGoogle Scholar
Higuchi Y. Chromosomal DNA, fragmentation in apoptosis and necrosis induced by oxidative stress. Biochem Pharmacol. 2003;66(8):1527–35.CrossRefPubMedGoogle Scholar
Xu N, Lao Y, Zhang Y, Gillespie DA. Akt: a double-edged sword in cell proliferation and genome stability. Journal of oncology. 2012;2012.Google Scholar
Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene. 2003;22(56):8983–98.CrossRefPubMedGoogle Scholar
Fan XM, Jiang XH, Gu Q, Ching YP, He H, Xia HH, et al. Inhibition of Akt/PKB by a COX-2 inhibitor induces apoptosis in gastric cancer cells. Digestion. 2006;73(2–3):75–83.CrossRefPubMedGoogle Scholar
Matsuoka J, Yashiro M, Sakurai K, Kubo N, Tanaka H, Muguruma K, et al. Role of the stemness factors Sox2, Oct3/4, and nanog in gastric carcinoma. J Surg Res. 2012;174(1):130–5.CrossRefPubMedGoogle Scholar